Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 801–900 of 999
Sonkodi, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157160 · Cited by 7
“Moreover, pks + E. coli causes damage, leading to mutations and genomic instability and promotes carcinogenesis and tumor development [30,34–36].”
Visual analysis of colorectal cancer and gut microbiota: A bibliometric analysis from 2002 to 2022
Long, D., Mao, C., Zhang, Z., Zou, J., & Zhu, Y. (2023) · Medicine · doi:10.1097/md.0000000000035727 · Cited by 4
“[80]”
Thomas, C. E., Georgeson, P., Qu, C., Steinfelder, R. S., Buchanan, D. D., Song, M., Harrison, T. A., Um, C. Y., Hullar, M. A. J., Jenkins, M. A., et al. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0600 · Cited by 4
Clinical efficacy of metformin in familial adenomatous polyposis and the effect of intestinal flora
Zhou, L., Zheng, L., Xu, B., Zhou, Y., Li, D., & Wang, W. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03064-6 · Cited by 4
“In patients with FAP, Dejea et al. [3] discovered a relationship between the polyposis and intestinal flora, which was mainly composed of polyke-tide synthase-positive Escherichia coli (pks + E. coli ) and enterotoxin-producing Bacteroides fragilis (ETBF) in † Linxin Zhou and Linfu Zheng…”
BackgroundKiouri, D. P., Batsis, G., Mavromoustakos, T., Giuliani, A., & Chasapis, C. T. (2025) · BioTech · doi:10.3390/biotech14010013 · Cited by 4
“It is hypothesized that the scale-free character of the degree distribution is at least partially due to gene duplication events, because it is thought to underlie the phenomenon of preferential attachment [121].”
Gut Bacteroides fragilis in health and diseases: an updated review
Yang, Y., Cao, X., Kato, N., & Wang, Y. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2024.11.025 · Cited by 8
Gómez‐Moreno, R., González‐Pons, M., Soto‐Salgado, M., Cruz-Correa, M. R., & Baerga‐Ortiz, A. (2019) · Diseases · doi:10.3390/diseases7010016 · Cited by 7
Huang, H., Xie, L., Feng, X., Zheng, Z., Ouyang, J., Li, Y., & Yu, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3211 · Cited by 5
“Active regulatory functions of nuclear miRNAs have been described in gene promoter regions and exert further effects via epigenetic pathways (6).”
BackgroundMezerová, K., Raclavský, V., & Starý, L. (2021) · Biomedical Papers · doi:10.5507/bp.2021.054 · Cited by 7
Plitt, T., & Faith, J. J. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101735 · Cited by 3
Campylobacter jejuni causes colorectal cancer
Gervaz, P., Campos, Á. D., & Caeiro, A. (2022) · World Journal of Colorectal Surgery · doi:10.4103/wjcs.wjcs_19_22 · Cited by 4
Neumann, S., Peyroux, E. M., Woodall, M. J., Shields, N. J., Young, S. L., & Pattison, S. T. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88137 · Cited by 6
Microbes in Tumoral In Situ Tissues and in Tumorigenesis
Xue, F., Han, L., Ma, S., Zhao, L., Wang, L., Zhang, K., Yin, P., Guo, L., Wei, J., & Li, Q. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572570 · Cited by 6
Zhang, X., Chen, X., Guo, Y., Gao, G., Wang, D., Wu, Y., Liu, J., Liang, G., Zhao, Y., & Wu, F. (2021) · Angewandte Chemie · doi:10.1002/ange.202102059 · Cited by 5
Microbiome and gastroesophageal disease: Pathogenesis and implications for therapy
D’Souza, S. M., Cundra, L. B., Yoo, B. S., Parekh, P. J., & Johnson, D. A. (2020) · Gastroenterology Hepatology and Endoscopy · doi:10.15761/ghe.1000199 · Cited by 4
Compositional Analysis of the Human Microbiome in Cancer Research
Morales, E., Chen, J., & Greathouse, K. L. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9027-6_16 · Cited by 5
Abril, A. G., Lanzi, P. G., & Notario, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-21862-1_16 · Cited by 4
Lance, P. (2019) · Springer eBooks · doi:10.1007/978-3-030-15935-1_14 · Cited by 5
Zhu, Y., Ma, L., Wei, W., Li, X., Chang, Y., Pan, Z., Gao, H., Yang, R., Bi, Y., & Ding, L. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001523 · Cited by 5
Overacre-Delgoffe, A. E., Cillo, A. R., Bumgarner, H. J., Burr, A. B. P., Tometich, J. T., Bhattacharjee, A., Bruno, T. C., Vignali, D. A. A., & Hand, T. W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.27.428417 · Cited by 4
“fragilis, can have a ‘pro-tumor’ effect by adhering to and directly interacting with colorectal tumors, driving mutagenesis and induction of inflammatory cytokines (Arthur et al., 2012; Dejea et al., 2018; Grivennikov et al., 2012; Kostic et al., 2013; Schwabe and Jobin, 2013; Sears and Garrett, 2014).”
BackgroundJans, M., Kolata, M., Blancke, G., Ciers, M., Dohlman, A. B., Kusakabe, T., Sze, M., Thiran, A., Berx, G., Tejpar, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553526 · Cited by 4
Zia, T., Khan, K., Aghayeva, S., & Uddin, R. (2024) · Biotechnology Letters · doi:10.1007/s10529-024-03537-5 · Cited by 3
“BFT is one of the most researched virulence factors of B. fragilis , and recent research indicates that it may have a role in the development of colorectal cancer and chronic colitis (Chung et al. 2018; Dejea et al. 2018; Snezhkina et al. 2016).”
Wouters, S., Moors, H., Verslegers, M., Leys, N., Malhotra‐Kumar, S., Kumar‐Singh, S., & Mysara, M. (2025) · STAR Protocols · doi:10.1016/j.xpro.2024.103517 · Cited by 5
Nambiar, J., Venugopal, M., Shaji, S. K., Bose, C., Rajeev, A., Kalliadan, S., Haripriyan, J., & Nair, B. G. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42538 · Cited by 4
“…reveal a high prevalence of patchy bacterial biofilms, composed of colibactin-producing E. coli and Bacteroides fragilis toxins, in biopsies of colorectal tumors from patients with familial adenomatous polyposis (FAP), further emphasizing the role of bacterial infections in cancer progression [36].”
Colorectal cancer chemoprevention: Exploring the path from molecular mechanisms to available drugs
Ivy, D. M., Bordone, R., Magno, L. D., Coni, S., & Canettieri, G. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189439 · Cited by 5
Wang, Q., & Ding, H. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09490-1 · Cited by 4
Perry, E. K., Udayasuryan, B., Zegeye, E. K., Rose, C. M., Reichelt, M., & Tan, M. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00854-z · Cited by 3
Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential
He, J., Tan, H. Z., Qiu, Y., Dan, Y., Wan, Q., Li, L., Wu, J., Song, Q., Chen, H., & Xu, B. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101963 · Cited by 5
“7,134,135 Phylum-level dominance includes Firmicutes and Bacteroidetes , with specificities like toxin-producing strains ( e.g. , pks + E. coli ) promoting DNA damage and inflammation.”
Unveiling hidden players: the role of intratumoral microbiota in gastrointestinal cancer dynamics
Tang, W., Li, F., Zheng, H., Zhou, S., Li, C., Xu, X., & Fu, J. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06401-9 · Cited by 5
“…repertoire includes the induction of DNA damage, the modulation of apoptosis, and the orchestration of epithelial–mesenchymal transition, thereby tipping the balance between tumour suppression and progression (Cao et al. 2021; Dejea et al. 2018; Mu et al. 2020 ; Yu et al. 2017; Tang et al. 2023).”
Unraveling the microbial landscape in prostate cancer: pathogenesis to therapy
Du, X., Wu, J., Xia, S., Zheng, H., & Zhang, B. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00900-w · Cited by 5
Zhang, R., Li, Z., Liu, X., Qiu, Z., Li, Y., Gao, C., & Guo, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1653727 · Cited by 4
Intracellular bacteria modulate the immune microenvironment of oral squamous cell carcinoma
Wang, Y., Lin, Q., Xiang, Z., Qi, R., Niu, M., Luo, X., Lei, L., Zou, Q., & Xu, L. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117019 · Cited by 7
Chemiluminescent Probes Allow for the Rapid Identification of Colibactin-Producing Bacteria
Ramos, M. A. A., Gutkin, S., David, M., Shabat, D., & Balskus, E. P. (2026) · JACS Au · doi:10.1021/jacsau.6c00004 · Cited by 3
Srinivasalu, V. K., Subramaniam, N., Ibrahim, M., & Das, M. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70420 · Cited by 5
“…Bacteroides fragilis promotes IL-17–driven inflammation associated with serrated pathway carcinogenesis, while colibactin-producing Escherichia coli induces DNA cross-linking damage and may act early in tumorigenesis, highlighting its potential role in identifying high-risk adenomas [59, 60].”
Rethinking Colorectal Cancer Microbiome: From Universal Biomarkers to Patient-Stratified Signatures
Schena, C. A., Laterza, V., Covino, M., & Rosa, F. (2026) · Gastrointestinal Disorders · doi:10.3390/gidisord8020026 · Cited by 3
Biofilm formation: A well-played game in bacterial pathogenesis
Thite, V. S., Bharathi, R. K., & Srinandan, C. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99977-9.00009-0 · Cited by 3
Wang, X., & Zhu, Z. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1422132 · Cited by 5
“Tumor-coating enterotoxigenic Bacteroides fragilis recruits other bacteria and immune cells to the tumor site and boosts colorectal cancer progression (Dejea et al., 2018).”
BackgroundLee, D. Y., Lee, S. Y., Jeong, J. W., Kim, J. H., Yun, S. H., Lee, J., Mariano, E., & Hur, S. J. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4470 · Cited by 5
“Potential roles of microorganisms in CRC development may include the production of growth factors for cancer cells, the formation of biofilms around tumors, and the production of mutagenic biomolecules (Arthur et al., 2012; Brennan & Garrett, 2019; Dejea et al., 2018).”
Bifidobacterial biofilms as next-generation probiotics and their role in intestinal microbiocenosis
Aziz, K., & Zaidi, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2438119 · Cited by 5
“…and modulation of the mucus barrier and the immune system (Buret et al. 2019). the disruption or alteration of mucosal biofilms is associated with a host of diseased conditions, as widely reported (Swidsinski et al. 2005; engel et al. 2012; Drewes et al. 2017; Dejea et al. 2018; Motta et al. 2018).”
Association of Intratumoral Microbiota with Prognosis in Patients with Lacrimal Gland Tumor
Hu, J., Yang, Y., Feng, Y., Yu, Y., Song, X., & Jia, R. (2025) · Biomedicines · doi:10.3390/biomedicines13040960 · Cited by 3
“Similarly, Pseudomonas aeruginosa can cause DNA damage and enhance the accumulation of reactive oxygen species through its toxin production, further complicating cancer pathology [34].”
Romeo, M., Nardo, F. D., Napolitano, C., Basile, C., Palma, C., Vaia, P., Dallio, M., & Federico, A. (2025) · Diabetology · doi:10.3390/diabetology6080079 · Cited by 4
Clarke, J. M., Lockett, T. J., Harrap, K. L., Flanders, B. E., Bird, V., Boussioutas, A., Appleyard, M. N., Williams, D. B., Zaloumis, S. G., Gupta, A., et al. (2025) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-24-0513 · Cited by 3
“The colonic mucosa of patients with FAP is covered with patchy bacterial biofilms composed predominantly of Escherichia coli and Bacteroides fragilis and is highly enriched with oncotoxins (colibactin clbB and Bacteroides fragilis toxin bft ) compared with healthy individuals (41).”
TNF-shaped microbiota promotes cancer
Trinchieri, G. (2020) · Nature Cancer · doi:10.1038/s43018-020-0090-y · Cited by 3
Cheng, A. V., & Wuest, W. M. (2020) · ACS in focus · doi:10.1021/acs.infocus.7e4006 · Cited by 3
Role of biofilm in host–pathogen interaction
Sharma, S., Sharma, S., & Tiwari, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88480-8.00016-9 · Cited by 3
Microbiome insights into pediatric familial adenomatous polyposis
Attard, T. M., Septer, S. S., Lawson, C. E., Attard, M. I., Lee, S. T. M., & Umar, S. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02569-2 · Cited by 7
“They are reported as a major phylum in colonic biofilms from FAP patients compared to healthy individuals [7].”
BackgroundInfluentialThe pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms
Zhou, P., Lu, S. L., Chang, L., Liao, B., Cheng, M. L., Xu, X., Sui, X., Liu, F.-T., Zhang, M., Wang, Y., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100882 · Cited by 3
Luo, P., Gao, D., & Zhang, Q. (2024) · Skin Research and Technology · doi:10.1111/srt.13804 · Cited by 2
“42 Previous research has underscored the significance of mucin-type O-polysaccharides in mediating their mutually advantageous effects and direct impact on the interaction between Bacteroides and host tissues.”
BackgroundRetractedBachelle, S. V., Bah, S. Y., Addo, R. T., Bediako‐Bowan, A., Egyir, B., Tsatsu, S. E., Dzudzor, B., & Amarh, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-74299-3 · Cited by 4
Global biogeography and projection of antimicrobial toxin genes
Liu, Y., Geng, Y., Jiang, Y., Sun, J., Li, J., Li, Y., & Zhang, Z. (2025) · Microbiome · doi:10.1186/s40168-025-02038-5 · Cited by 4
Photoactivated Colibactin Probes Induce Cellular DNA Damage
Moodie, L. W. K., Hubert, M., Zhou, X. M., Albers, M. F., Lundmark, R., Wanrooij, S., & Hedberg, C. (2018) · Angewandte Chemie · doi:10.1002/ange.201812326 · Cited by 4
Flow-induced symmetry breaking in growing bacterial biofilmsPreprint
Pearce, P., Song, B., Skinner, D. J., Mok, R. V., Hartmann, R., Singh, P. K., Jeckel, H., Oishi, J. S., Drescher, K., & Dunkel, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/627208 · Cited by 3
Zhao, H. (2021) · Human Genetics · doi:10.1007/s00439-021-02277-0 · Cited by 3
“Similarly, in cancer, the microbiome is now recognized as playing key roles in inflammation, the immune response and the generation of toxic metabolites, thereby contributing to the process of carcinogenesis (Coker 2018; Dejea 2018; Tanoue 2019).”
BackgroundMolecular Signatures for Microbe-Associated Colorectal CancersPreprint
Sayed, I. M., Vo, D. T., Alcantara, J. A., Inouye, K., Pranadinata, R. F., Luo, L., Boland, C. R., Goyal, N. P., Kuo, D. J., Huang, S. C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.26.595902 · Cited by 3
“Microbial biofilms are implicated in driving CRCs in Lynch and FAP syndromes; genetically engineered mouse models show that specific bacteria can induce colon inflammation and tumor formation [17, 18].”
BackgroundSticky situation: how adhesive bacteria drive colon cancer
Ouyang, K. S., & Puschhof, J. (2024) · Nature · doi:10.1038/d41586-024-03285-6 · Cited by 2
Introduction to microbiomes in health and diseases
Agrawal, P., Mendhey, P., Kumar, R., Patel, S., Kaushik, P. K., Dadsena, A., & Kumar, S. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.010 · Cited by 3
Kim, Y. J., Lee, J., Lee, E., Park, S. J., & Kim, J. H. (2025) · Intestinal Research · doi:10.5217/ir.2025.00011 · Cited by 2
“19 In this context, metformin’s anti-tumorigenic effects, mediated through AMPK activation and inhibition of NF-κ B signaling, have been demonstrated in various cancer models.”
Bacterial profiling of colorectal cancer biopsies: a culture-based study in Indian patients
Kushwaha, M., Chaudhary, S., Singh, A. K., Makharia, G., & Kumar, A. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1535477 · Cited by 2
A possible role of urinary genotoxic Escherichia coli in prostate cancer in Nigerian patients
Akinpelu, S. O., Olasehinde, G. I., & Akinnola, O. O. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07369-y · Cited by 2
“Epidemiological studies on colorectal cancer (CRC) have shown that people who have been diagnosed with the disease are more likely to have pks+/clb + E. coli strains in their gut microbiota [6, 11].”
Molecular basis of DNA cross-linking by bacteria
Schärer, O. D. (2025) · Science · doi:10.1126/science.aec9205 · Cited by 2
Wu, Y., Zhou, M., Wan, Y., Wei, K., Ma, S., Cheng, L., Lin, T., He, L., He, Y., & Zhou, F. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1695187 · Cited by 3
“In the colon, tumor-prone mice harboring enterotoxigenic strains of Bacteroides fragilis exhibit elevated IL-17 expression, increased epithelial DNA damage, accelerated tumor progression, and higher mortality rates (Dejea et al., 2018).”
Harnessing engineered bacteria for revolutionizing cancer immunotherapy
Zhou, K., Cao, L., Luo, H.-Y., Wang, K.-N., Song, Z., & Bu, L. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01664-3 · Cited by 2
Zhang, Y., Zhang, B., Pang, W., Gu, W., Wang, X., Yuan, H., Fang, S., Zhang, J., Li, X., Xing, X., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02378-w · Cited by 2
“For instance, colibactin secreted by pks + E. coli induces DNA interstrand crosslinks, leading to mutations in colonic epithelial cells and promoting CRC tumorigenesis [11, 12].”
Zhang, H., Zhang, X., Guo, J., Huang, X., An, M., Wang, S., Wang, S., & Fu, B. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11858-z · Cited by 2
Walberg, Ã., Reuss, A. M., Ziadlou, R., Mamie, C., Gottier, C., White, A., Ameri, M., Brüggen, M., Turina, M., Ramser, M., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2665878 · Cited by 6
“3,25 26-28 In our present study, we analyzed paired CRC tissue and adjacent intestinal tissue from the same patient.”
Gut microbiota and diet in colorectal cancer: Converging determinants of carcinogenesis
Thakur, B. K., Choudhury, S. R., Turpin, W., & Martín, A. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2664684 · Cited by 4
“38,102 ETBF frequently colocalizes with pks ⁺ E. coli in mucosal biofilms, particularly in patients with familial adenomatous polyposis, and enhances pks ⁺ E. coli -driven tumorigenesis by fostering an IL-17-rich inflammatory milieu.”
Ahn, J. A. O. K., Hazelton, A., Nguyen, J., & Arthur, J. C. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01725-z · Cited by 2
“Tumor-associated mucosal bio fi lms enriched in E. coli have also been identi fi ed in familial adenomatous polyposis, linking bio fi lm-driven persistence and toxin production to colorectal tumorigenesis 100 .”
Sun, B., & Wang, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1768792 · Cited by 4
The gut microbiome in colorectal cancer: molecular paradigms and translational frontiers
Liu, Y., & Mei, D. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1864299 · Cited by 2
“ETBF drives oncogenesis through secretion of the B. fragilis toxin (BFT), a 20-kDa zinc-dependent metalloprotease (Dejea et al., 2018).”
Li, L., Shi, X., Liu, M., Xu, T., Chen, Y., Wang, R., Zhang, Q., & Li, D. (2026) · Pathogens · doi:10.3390/pathogens15070687 · Cited by 2
“Furthermore, longitudinal sampling along the cancer continuum—from precancerous lesions, carcinoma in situ, to invasive cancer—is critical for defining stage-specific microbial colonization dynamics and their temporal association with tumor progression [110].”
Bacteroides acidifaciens enriched by KRAS mutation promotes colorectal tumorigenesis
Jiao, Y., Cheng, C. H., Gao, X., Li, W., Ji, F., Liang, C., Huang, P., Ko, L. H., Ye, L., Kam, I. C. H., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.08.010 · Cited by 2
Esophageal dysbiosis and pathogenesis of gastroesophageal reflux disease
D’Souza, S. M., Vallabhaneni, M., Houston, K. V., Cundra, L. B., Vilela, A., Yoo, B. S., & Johnson, D. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95070-1.00003-5 · Cited by 3
Quantitative whole-tissue 3D imaging reveals bacteria in close association with mouse jejunum mucosa
Poceviciute, R., Bogatyrev, S. R., Romano, A. E., Dilmore, A. H., Mondragón-Palomino, O., Takko, H., Pradhan, O., & Ismagilov, R. F. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00423-2 · Cited by 2
“Some potential mechanisms for this synergy are metabolic coupling [21, 47, 53], mucosal adhesion [45, 54], and modulation .”
Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
Tu, S., Aydın, A. M., Maraboyina, S., Chen, Z., Singh, S. R. K., Gökden, N., & Langford, T. (2023) · Cancers · doi:10.3390/cancers15225385 · Cited by 2
Identifications of the potential in-silico biomarkers in lung cancer tissue microbiomes
Ma, Z. S., & Li, L. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109231 · Cited by 3
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohort
Drewes, J. L., Rifkin, S. B., McMann, M., Glass, S., Spence, E., Wensel, C. R., Geis, A. L., Stevens, C. M., Gills, J. J., Wang, H., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2452233 · Cited by 4
“1,2,4 Finally, our comparison of different fixatives (FFPE vs. methacarn) revealed that although mucus was better preserved by methacarn, the FFPE scores for adherent or invasive bacteria within 1 µm of the epithelium were comparable to methacarn bacterial scores.”
Self-citationBacteria, stem cells and cancer
Pani, G. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00876-x · Cited by 2
Green, E. H., Kotrannavar, S., Rutherford, M. E., Lunnemann, H. M., Kaur, H., Heiser, C. N., Ding, H., Simmons, A. J., Liu, X., Lacy, D. B., et al. (2025) · The Journal of Pathology · doi:10.1002/path.6406 · Cited by 6
“Bacterial colonization of mouse models for interrogating mechanisms of CRC tumorigenesis has included enterotoxigenic Bacteroides fragilis , pks + E. coli , F. nucleatum , and bacterial bio fi lms [4,6,9 – 11].”
Self-citationStructural and functional alteration of the gut microbiomes in ICU staff: a cross-sectional analysis
Xie, B., Dong, C., Zhao, X., Qu, L., Lv, Y., Liu, H., Xu, J., Yu, Z., Shen, H., Shang, Y., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05379-7 · Cited by 3
Chen, F., Zhou, Y., Mao, X., Lin, R., & Huang, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02761-3 · Cited by 2
Stewart, E. C., Almatani, M. F., Hayden, M., Rompato, G., Case, J., Rice, S., Hintze, K. J., & Benninghoff, A. D. (2025) · Nutrients · doi:10.3390/nu17152482 · Cited by 3
“Increases in pathobionts, such as Fusobacterium nucleatum and Escherichia coli , have been linked to barrier disruption and pro-inflammatory signaling, with some species identified directly within tumor tissue [12,13].”
Role of the Microbiome in the Formation and Development of Colorectal Cancer
Zwinsova, B., Brychtová, V., Hrivňáková, M., Dubská, L. Z., Bencsiková, B., Nenutil, R., Vídeňská, P., & Budínská, E. (2019) · Klinicka onkologie · doi:10.14735/amko2019261 · Cited by 4
Local cellular cues that influence the immunology of colorectal cancer treatment
Donaldson, G. P., & Mucida, D. (2020) · Nature Medicine · doi:10.1038/s41591-020-0902-8 · Cited by 2
Роль кишечной микробиоты в патогенезе колоректального рака. Обзор литературных данных
Карасев, И. А., Malikhova, O. A., & Давыдкина, Т. С. (2020) · Malignant tumours · doi:10.18027/2224-5057-2020-10-3s1-60-62 · Cited by 3
Metabolic reprogramming and immunity in cancer
Chen, Y., & Li, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00006-5 · Cited by 2
Chakaroun, R., Massier, L., Musat, N., & Kovacs, P. L. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1756-4509 · Cited by 2
Correlation between Microbiota and Oncogenesis: Research Progress
宋, 晓. (2020) · Bioprocess · doi:10.12677/bp.2020.103003 · Cited by 2
The Microbiome in Gastrointestinal Cancers
White, M. G., & Wargo, J. A. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.007 · Cited by 2
The Gut Microbiome and Colorectal Cancer
Yu, A. I., & Chen, G. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_3 · Cited by 3
Roughening instability of growing 3D bacterial coloniesPreprint
Martínez-Calvo, A., Bhattacharjee, T., Bay, R. K., Luu, H. N., Hancock, A. M., Wingreen, N. S., & Datta, S. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.09.491177 · Cited by 2
Immune-oncology-microbiome axis may result in AKP or anti-AKP effects in intratumor microbiomesPreprint
Ma, Z. S. (2024) · medRxiv · doi:10.1101/2024.03.23.24304783 · Cited by 2
Letourneur, D., Bergsten, E., Raynaud, N., Mondy, J., Nigro, G., Tsoumtsa, L. L., Vaysse, A., Descorps‐Declère, S., Yoshida, A. E., Stefani, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.02.680056 · Cited by 2
Programmable conjugative CRISPR interference targeting genotoxin in the gutPreprint
Hamp, B., Timek, H., Fang, C., Fang, C., Haley, A. E., Jennings, M., Chimezie, C. I., Hutchinson, N., Dong, Z., McCollum, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.13.682122 · Cited by 5
Wren, J. T., & Wardenburg, J. B. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.013 · Cited by 1
Mizutani, S., Tamaki, A., Shiba, S., Salim, F., Yamada, M., Takamaru, H., Nakajima, T., Yoshida, N., Ikuta, S., Yachida, T., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332381 · Cited by 1
González, E. A. P., & Haider, K. H. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_50 · Cited by 2
Influence of Intestinal Flora on ICB Therapy for Colorectal Cancer
赵, 飞. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14123181 · Cited by 2
Fongmanee, J., Wanitsuwan, W., Wanna, W., Surachat, K., Saechan, C., Srinoun, K., Buncherd, H., Thanapongpichat, S., Kanjanapradit, K., & Tansila, N. (2025) · Genes to Cells · doi:10.1111/gtc.70008 · Cited by 1
“Similarly, E. coli and B. fragilis have been found to be more abundant in the colonic biofilms of patients with FAP, as well as in CRC-prone mouse models with inactivated APC genes (Dejea et al. 2018; Son et al. 2015).”
Three-Dimensional Imaging of Native Microbiota in Intact Colon
Du, Y., Zhou, Y., Lin, H., Yang, C. J., & Wang, W. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06059 · Cited by 1
Understanding oncobiosis in ovarian cancer: Emerging concepts in tumor progression
Sharma, P., Das, S., Rituraj, R., & Bhagyashree, B. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156026 · Cited by 1
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.